carbamates has been researched along with Mental Disorders in 25 studies
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the first case of repaglinide-induced factitious hypoglycemia in a young male." | 7.71 | Repaglinide-induced factitious hypoglycemia. ( Brennan, R; Csako, G; Gorden, P; Hirshberg, B; Pucino, F; Skarulis, MC, 2001) |
| "We report the first case of repaglinide-induced factitious hypoglycemia in a young male." | 3.71 | Repaglinide-induced factitious hypoglycemia. ( Brennan, R; Csako, G; Gorden, P; Hirshberg, B; Pucino, F; Skarulis, MC, 2001) |
| "Propamocarb (PM) is a type of fungicide, which is widely used in the greenhouse-based production of vegetables and fruits globally." | 1.51 | Propamocarb exposure decreases the secretion of neurotransmitters and causes behavioral impairments in mice. ( Fu, Z; Jin, C; Jin, Y; Shen, M; Wang, X; Wu, S; Zhang, Y; Zhou, J, 2019) |
| "Treatments in Alzheimer's disease include treatment of cognitive impairment and behavioral manifestations (agitation, depression, anxiety, delusions)." | 1.30 | [Drug therapy strategies in Alzheimer's disease]. ( Lacomblez, L, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (68.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Jin, C | 1 |
| Wang, X | 1 |
| Shen, M | 1 |
| Zhou, J | 1 |
| Wu, S | 1 |
| Fu, Z | 1 |
| Jin, Y | 1 |
| Gabelli, C | 1 |
| HELD, R | 1 |
| VERMOREL, M | 1 |
| VERMOREL, H | 1 |
| ROULLET, A | 1 |
| UHR, L | 1 |
| MILLER, JG | 1 |
| GIBBS, AE | 1 |
| WYKES, PR | 1 |
| MEYER, J | 1 |
| BUSWELL, M | 1 |
| RODMAN, FB | 1 |
| SHUBIN, H | 1 |
| STEINBERG, N | 1 |
| HSU, JJ | 1 |
| BRAUN, RA | 1 |
| DOMINO, EF | 1 |
| LOWINGER, P | 1 |
| SCHORER, C | 1 |
| BRUCK, M | 1 |
| D AMELIO, V | 1 |
| ANNOVI, G | 1 |
| JUILLET, P | 1 |
| SAVELLI, A | 1 |
| BOUVIER, S | 1 |
| RIGAL, J | 1 |
| ELIS, B | 1 |
| Finkel, SI | 1 |
| Preskorn, SH | 1 |
| Borges-Gonzalez, S | 1 |
| Flockhart, D | 1 |
| Tetreault, L | 1 |
| Richer, P | 1 |
| Bordeleau, JM | 1 |
| Hirshberg, A | 1 |
| Lerman, Y | 1 |
| Lacomblez, L | 1 |
| Hirshberg, B | 1 |
| Skarulis, MC | 1 |
| Pucino, F | 1 |
| Csako, G | 1 |
| Brennan, R | 1 |
| Gorden, P | 1 |
| Ayd, FJ | 1 |
| Fransway, RL | 1 |
| Wells, ML | 1 |
| Chen, CH | 1 |
| Pennington, VM | 1 |
| Cousin, JP | 1 |
4 reviews available for carbamates and Mental Disorders
| Article | Year |
|---|---|
Rivastigmine: an update on therapeutic efficacy in Alzheimer's disease and other conditions.
Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cognition; Disease Progression; Economics | 2003 |
Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease.
Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Humans; Mental D | 2004 |
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II.
Topics: Anti-HIV Agents; Antidepressive Agents; Antiparkinson Agents; Apomorphine; Atazanavir Sulfate; Azabi | 2006 |
Understanding changes in cholinergic function: implications for treating dementia.
Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinergic Fibers; Cholinesterase Inhibi | 2002 |
3 trials available for carbamates and Mental Disorders
| Article | Year |
|---|---|
A clinical evaluation of the hypnotic efficacy and safety of mebutamate.
Topics: Adult; Aged; Anxiety Disorders; Bipolar Disorder; Blood Pressure; Carbamates; Dose-Response Relation | 1972 |
Tybamate in the treatment of chronic mental patients.
Topics: Carbamates; Clinical Trials as Topic; Female; Humans; Male; Mental Disorders; Placebos; Tranquilizin | 1967 |
Evaluation of tybamate in mental disorders.
Topics: Brain Diseases; Carbamates; Family Characteristics; Humans; Marriage; Mental Disorders; Neurotic Dis | 1969 |
18 other studies available for carbamates and Mental Disorders
| Article | Year |
|---|---|
Propamocarb exposure decreases the secretion of neurotransmitters and causes behavioral impairments in mice.
Topics: Animals; Behavior, Animal; Carbamates; Colon; Dopamine; Fungicides, Industrial; Locomotion; Male; Me | 2019 |
[Trial therapy with methylpentynol carbamate in ambulatory psychiatric treatment].
Topics: Carbamates; Electroconvulsive Therapy; Hypnotics and Sedatives; Mental Disorders; Psychosurgery; Psy | 1956 |
[Use of methylpentyne-ol carbamate in large doses in psychiatry].
Topics: Carbamates; Electroconvulsive Therapy; Hypnotics and Sedatives; Mental Disorders; Psychiatry; Psycho | 1958 |
Experimentally determined effects of emylcamate (striatran) on performance, autonomic response, and subjective reactions under stress.
Topics: Autonomic Nervous System; Carbamates; Humans; Mental Disorders; Mental Processes; Stress, Physiologi | 1960 |
The use of methylpentynol carbamate in a geriatric unit.
Topics: Carbamates; Dementia; Geriatrics; Humans; Mental Disorders; Psychotic Disorders | 1960 |
Sedation in geriatrics using methylpentynol carbamate.
Topics: Aged; Carbamates; Dementia; Geriatrics; Humans; Hypnotics and Sedatives; Mental Disorders; Psychotic | 1960 |
Impressions of the possible effects of a new tranquilizer, hydroxyphenamate.
Topics: Butylene Glycols; Carbamates; Humans; Hypnotics and Sedatives; Mental Disorders; Tranquilizing Agent | 1962 |
Clinical trials of a monocarbamate.
Topics: Anti-Anxiety Agents; Carbamates; Esters; Humans; Mental Disorders; Tranquilizing Agents | 1960 |
A STUDY OF A NEW TRANQUILIZER IN GENERAL PRACTICE: EMYLCAMATE IN 400 PATIENTS.
Topics: Carbamates; General Practice; Humans; Mental Disorders; Meprobamate; Neurotic Disorders; Pennsylvani | 1963 |
CLINICAL EVALUATION OF HYDROXYPHENAMATE IN PSYCHOTIC PATIENTS.
Topics: Anxiety; Brain; Brain Damage, Chronic; Butylene Glycols; Carbamates; Humans; Mental Disorders; Psych | 1963 |
[TREATMENT WITH MEBUTAMATE (AN ANTIHYPERTENSIVE WITH CENTRAL ACTION) OF MENTAL PATIENTS WITH HYPERTENSIVE MANIFESTATIONS].
Topics: Alcoholism; Antihypertensive Agents; Anxiety; Bipolar Disorder; Carbamates; Dementia; Epilepsy; Huma | 1963 |
[PSYCHOPATHOLOGICAL MANIFESTATIONS IN THE COURSE OF FILARIASIS (APROPOS OF 3 CASES)].
Topics: Carbamates; Electroencephalography; Filariasis; Humans; Mental Disorders; Neurologic Manifestations; | 1964 |
Hypnotic properties of mebutamate: a comparative study of mebutamate, secobarbital and placebo in psychiatric patients.
Topics: Adult; Antihypertensive Agents; Carbamates; Humans; Hypnotics and Sedatives; Male; Mental Disorders; | 1967 |
Clinical problems in organophosphate insecticide poisoning: the use of a computerized information system.
Topics: Adolescent; Adult; Aged; Atropine; Carbamates; Child; Child, Preschool; Cholinesterase Inhibitors; C | 1984 |
[Drug therapy strategies in Alzheimer's disease].
Topics: Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Car | 1998 |
New insights into genetics and pathophysiology of Alzheimer's disease: what are the clinical and therapeutic implications?
Topics: Acetylcholinesterase; Alzheimer Disease; Brain; Butyrylcholinesterase; Carbamates; Cholinesterase In | 2000 |
Repaglinide-induced factitious hypoglycemia.
Topics: Adolescent; Blood Glucose; Carbamates; Diagnosis, Differential; Fasting; Humans; Hypoglycemia; Hypog | 2001 |
[Psychological reactions to tuberculous disease; use of 2 modifiers of behavior, dominal and statran].
Topics: Carbamates; Humans; Mental Disorders; Thiazines; Tranquilizing Agents; Tuberculosis | 1964 |